Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001814189-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 8, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
5,035
Total Value
$115,545.95
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Sep 4, 2026 | Sale | 3,745 | $24.35 | $91,190.75 | 163,854 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 8, 2026 | Sale | 1,290 | $18.88 | $24,355.20 | 162,564 | Direct | โ | View Details |